Global Contract Pharmaceutical Packaging Market, By Product (Sterile and Non-Sterile), Manufacturing Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules), Industry (Small Molecule, Biopharmaceutical, Vaccine)-Industry Trends and Forecast to 2029.
Global Contract Pharmaceutical Packaging Market Analysis and Size
With the rising number of products introduced in the market on a daily basis, one has to follow a proper mechanism to transport the product from the manufacturer to the end-user. The United States, which represents the world's largest market in pharmaceutical contract packaging, contributed for approximately one-third of total global revenue.
- Data Bridge Market Research analyses that the contract pharmaceutical packaging market was valued at USD 12.80 billion in 2021 and is expected to reach the value of USD 23.53 billion by 2029, at a CAGR of 7.9% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, import/export analysis, pricing analysis, production consumption analysis, patent analysis and technological advancements.
Global Contract Pharmaceutical Packaging Market Definition
The outsourcing of secondary tasks such as product packaging and labelling to third parties is known as contract pharmaceutical packaging. A contract pharmaceutical packager offers a wide range of services, installations, and equipment, from drug packaging design to drug testing. Secondary packaging businesses are used by pharmaceutical companies because they are more flexible, profitable, and allow them keep up with changing circumstances. A competent packager provides advantages to the company, such as brand recognition and client preferences.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Sterile and Non-Sterile), Manufacturing Packaging (Plastic Bottles, Caps and Closures, Blister Packs, Prefilled Syringes, Parenteral Vials and Ampoules), Industry (Small Molecule, Biopharmaceutical, Vaccine)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Catalent, Inc. (US), Thermo Fisher Scientific Inc (US), Baxter (US), AbbVie Inc. (US), Pfizer Inc. (US), DAITO DENKI INDUSTRY CO., LTD (Japan), Reed-Lane (US), TricorBraun (US), NIPRO (Japan), Amcor plc (Switzerland), BALL CORPORATION (US), West Pharmaceutical Services, Inc. (US), WestRock Company. (US), Gerresheimer AG (Germany) CCL Industries Inc. (Canada)
|
|
Market Opportunities
|
|
Contract Pharmaceutical Packaging Market Dynamics
Major factors that are expected to boost the growth of the contract pharmaceutical packaging market are as follows:
-
Rise in the Aging Population
Growing of the geriatric population and the increase in the healthcare spending on them is one of the chief contributors of the market growth.
-
Growing of Public Interest for Modernised Packaging
Pharmaceutical contract packaging businesses can handle a wide range of packaging tasks and respond swiftly to challenges arising from a variety of packaging requirements which is anticipated to propel the market growth rate.
-
Increase in the Number of New Drug Approvals by FDA
According to Food and Drug Administration (FDA) rules in the United States, pharmaceutical medications require high barrier packaging materials and sealants that are impermeable and resistant to solvents, grease, chemicals, and heat which is further driving the market.
Opportunities
Decline in the operational costs and growing need for sustainable packaging will further provide potential opportunities for the growth of the contract pharmaceutical packaging market in the coming years.
Restraints/Challenges Global Contract Pharmaceutical Packaging Market
On the other hand, the contract pharmaceutical packaging industry is a relatively new industry which is further projected to impede the growth of the contract pharmaceutical packaging market in the timeline period however, the dearth of workforce and limitations in transportation might further challenges the growth of the contract pharmaceutical packaging market in the near future.
This contract pharmaceutical packaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the contract pharmaceutical packaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Contract Pharmaceutical Packaging Market
The recent outbreak of coronavirus has positively impacted the contract pharmaceutical packaging market. Throughout the outbreak, the race to develop a COVID-19 vaccine underlined the critical importance of viral vectors in the virotherapy and vaccine industries in delivering successful vaccines and pharmaceutical therapies. As a result, it also showcased the industry's remarkable adaptability and innovation. The hunt for a vaccine displaced existing capacity and clinical development programmes, but it sparked unprecedented industrial collaboration. Outsourcing medicine development and production to viral vector expert CDMOs, was emphasised as an advantage of collaboration during the pandemic. These alliances provide a lot of advantages, particularly to smaller biotechs with limited resources to invest in their own capabilities.
On the optimistic side, the manufacturers are focusing on developing better products, keeping in mind the new market trends to fulfil consumer requirements in the post-pandemic phase. New technological advancements will further help to excel the availability of contract pharmaceutical packaging in the developing and emerging markets post pandemic.
Recent Development
- Amcor announced the launch of their innovative recyclable healthcare packaging in April 2021, which is also the first recyclable Polyethylene based thermoform blister packaging in the world.
Global Contract Pharmaceutical Packaging Market Scope
The contract pharmaceutical packaging market is segmented on the basis of product, manufacturing packaging and industry. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Sterile
- Non-Sterile
On the basis of product, the contract pharmaceutical packaging market has been segmented into sterile and non-sterile.
Manufacturing Packaging
- Plastic Bottles
- Caps and Closures
- Blister Packs
- Prefilled Syringes
- Parenteral Vials
- Ampoules
On the basis of manufacturing packaging, the contract pharmaceutical packaging market is segmented into plastic bottles, caps and closures, blister packs, prefilled syringes, parenteral vials and ampoules.
Industry
- Small Molecule
- Biopharmaceutical
- Vaccine
On the basis of industry, the contract pharmaceutical packaging market is segmented into small molecule, biopharmaceutical, and vaccine.
Contract Pharmaceutical Packaging Market Regional Analysis/Insights
The contract pharmaceutical packaging market is analysed and market size insights and trends are provided by country, product, manufacturing packaging and industry as referenced above.
The countries covered in the contract pharmaceutical packaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, Israel, Egypt, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the contract pharmaceutical packaging market due to the rise in the healthcare expenditure and growing aging population. Furthermore, the rising value of pharmaceutical exports will further boost the growth of the contract pharmaceutical packaging market in the region during the forecast period.
Asia-Pacific is projected to observe significant amount of growth in the contract pharmaceutical packaging market due to the occurrence of a huge number of contract packaging service providers. Moreover, the rising demand of pharmaceuticals companies is further anticipated to propel the growth of the contract pharmaceutical packaging market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Contract Pharmaceutical Packaging Market Share Analysis
The contract pharmaceutical packaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to contract pharmaceutical packaging market.
Some of the major players operating in the contract pharmaceutical packaging market are:
- Catalent, Inc. (US)
- Thermo Fisher Scientific Inc (US)
- Baxter (US)
- AbbVie Inc. (US)
- Pfizer Inc. (US)
- DAITO DENKI INDUSTRY CO., LTD (Japan)
- Reed-Lane (US)
- TricorBraun (US)
- NIPRO (Japan)
- Amcor plc (Switzerland)
- BALL CORPORATION (US)
- West Pharmaceutical Services, Inc. (US)
- WestRock Company. (US)
- Gerresheimer AG (Germany)
- CCL Industries Inc. (Canada)
SKU-
